Delving into the Latest Updates on Synphatec (Shanghai) Biopharmaceutical Technology Co., Ltd. with Synapse

Overview

Tags

Nervous System Diseases

Neoplasms

Skin and Musculoskeletal Diseases

Recombinant polypeptide

Small molecule drug

Chemical drugs

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Nervous System Diseases	3
Neoplasms	1

Top 5 Drug Type	Count

Small molecule drug	1
Chemical drugs	1
Recombinant polypeptide	1

Top 5 Target	Count

APOE(Apolipoprotein E)	1
NMDA receptor(Glutamate [NMDA] receptor)	1

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 11 Mar 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

2

1

Phase 1

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

SP-101(Slyptai)	Depressive Disorder More	Phase 1
EP4471054 ( APOE )Patent Mining	Nervous System Diseases More	Discovery
WO2025124571 ( NMDA receptor )Patent Mining	Nervous System Diseases More	Discovery